WaveGuide has filed a notice of an exempt offering of securities to raise $33,104,984.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, WaveGuide is raising $33,104,984.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Nelson Stacks played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About WaveGuide
WaveGuide Corporation develops medical and industrial diagnostic devices built upon a breakthrough handheld nuclear magnetic resonance (NMR) platform. Qualitative and quantitative in-situ analysis spanning applications from biological samples, BioPharma, Food, Oils & Lubricants, THC/Cannabis through medical diagnostics (tuberculosis and ovarian cancer are 513(g) predicate device approved by the US FDA). Time domain NMR measures the time required for nuclei to return to equilibrium after excitation. It is widely recognized as a reliable, convenient, rapid analytical methodology that shows high reproducibility without the need for sample preparation and is non-destructive.
To learn more about WaveGuide, visit http://waveguidecorp.com/
Contact:
Nelson Stacks, Chief Executive Officer
617-892-9700
https://www.linkedin.com/in/nelson-stacks-319a5711/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.